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Abstract 
 
We demonstrated previously that ethanol inhibition of NMDA receptor (NMDAR) 
function is accompanied by a reduction in tyrosine phosphorylation of Tyr1472 on 
the NR2B subunit, and this action of ethanol is attenuated by a broad spectrum 
tyrosine phosphatase inhibitor. Here we examined whether this ethanol inhibition 
of NMDAR activity was due to the actions of STriatal Enriched protein tyrosine 
Phosphatase (STEP) which has been shown to regulate NMDAR internalization by 
dephosphorylating Tyr1472 on the NR2B subunit. Using whole-cell recordings of 
pharmacologically isolated NMDAR-mediated excitatory post-synaptic currents 
(NMDA EPSCs) from hippocampal CA1 pyramidal neurons, we show that 
intracellular infusion of a substrate-trapping inactive form of STEP (TAT-STEP 
C/S) significantly blocks ethanol inhibition of NMDA EPSCs. Ethanol does not 
inhibit NMDA EPSCs or LTP in neurons from STEP knockout mice, but its effect is 
restored after acute intracellular delivery of wild type TAT-STEP, suggesting that 
STEP mediates ethanol inhibition of NMDAR function.  
 
The majority of excitatory synaptic transmission in the mammalian CNS is mediated by 
the neurotransmitter glutamate, which activates postsynaptic α-amino-3-hydroxy-5-
methyl-4-isoxalone propionic acid (AMPA), kainate and N-methyl-D-aspartate (NMDA) 
subtypes of ionotropic glutamate receptors1. NMDA receptors (NMDARs) in the 
hippocampus consist of NR1/NR2A, NR1/NR2B, and NR1/NR2A/NR2B receptor 
subunit complexes2,3. While NR1 subunits are required to form an active ion channel, 
incorporation of the various NR2 subunits regulate NMDAR channel activity by altering 
the channel kinetics and/or mediating the differential effects of pharmacological agents 
including ethanol.  
 Acute ethanol application inhibits NMDAR channel activity4. In the hippocampus, 
this inhibitory effect of ethanol on NMDARs is widely thought to underlie both the acute 
amnestic effects of ethanol and also, in part, the addictive nature of ethanol5. However, 
the precise molecular mechanisms underlying ethanol’s inhibition of NMDARs have not 
been well-understood. We previously demonstrated that ethanol inhibition of NMDAR 
function is associated with dephosphorylation of tyrosine residues on the NR2A and 
NR2B subunits6. In particular, ethanol reduced phosphorylation of a site, Tyr1472, on the 
NR2B subunit which regulates endocytosis of NMDARs7,8. Moreover, ethanol-induced 
inhibition of NMDAR function was prevented by bath application of the protein tyrosine 
phosphatase (PTP) inhibitor, bpV(phen). Based on these and other findings that 
showed ethanol reduced the tyrosine phosphorylation of NR2 subunits in the cortex9, 
we proposed that ethanol inhibition of NMDAR activity is mediated by a PTP.   
PTPs are a large family of enzymes that are broadly divided into receptor-like PTPs 
and intracellular PTPs10,11,12, and are implicated in a number of neuronal  
functions13,14,15,16. STriatal Enriched protein tyrosine Phosphatase (STEP) is a brain-
specific PTP expressed in the striatum, hippocampus and cortex among other brain 
regions17,18. Within neurons, STEP is localized to the endoplasmic reticulum19 and in 
postsynaptic densities of glutamatergic synapses20. Of the four STEP isoforms, STEP61 
is the only one expressed in the hippocampus18. STEP61 forms a complex with the 
NMDAR, reduces its activity, and opposes the induction of long-term potentiation  
(LTP)21, a form of plasticity widely thought to play a role in learning and memory22. The 
current hypothesis for STEP function is that it blocks the development of synaptic 
strengthening23,24. Consistent with these findings, enhanced STEP activity is associated 
with dephosphorylation of the Tyr1472 residue on the NR2B subunit25, a site that is 
dephosphorylated by ethanol6. In addition, NMDAR trafficking to synaptic membranes is 
increased after RNA interference of STEP23. Based on these data, we predicted that 
STEP mediates the inhibitory effects of ethanol on NMDARs in various brain regions, 
including the hippocampus. We utilized whole-cell recordings of pharmacologically 
isolated NMDA EPSCs in both rat and mouse hippocampal slices. Moreover, we utilized 
the recently generated STEP KO mice26 to further test the hypothesis. Our results show 
that STEP is responsible, at least in part, for the inhibitory effects of ethanol on 
hippocampal NMDAR activity.   
 
Results 
 
Pretreatment of hippocampal slices with bpV(phen) attenuates the effects of 
ethanol on NMDA EPSCs. 
Since the previous work with ethanol and the broad spectrum tyrosine phosphatase 
inhibitor bpV(phen) was determined using extracellular NMDA field EPSPs (fEPSPs)6, 
we first verified that bpV(phen) attenuates ethanol inhibition of NMDAR function in 
individual pyramidal neurons from rat hippocampal slices. Control or 30 min of 10 μM 
bpV(phen)-treated hippocampal slices were transferred to a submersion-type recording 
chamber, perfused with aCSF for 10 min, and monitored with whole-cell recordings in 
CA1 pyramidal neurons to examine the effects of ethanol. The NMDA EPSCs were 
evoked by electrical stimulation of synaptic inputs in the stratum pyramidale. Control 
NMDA EPSCs were inhibited by 35 ± 4% in response to bath application of ethanol (80 
mM; Figure 1).  In contrast, slices pre-treated with bpV(phen) did not show reduced 
NMDA EPSCs in response to ethanol. These results confirm earlier work by Alvestad et 
al.6 and indicate that PTPs may be involved in mediating the inhibitory effects of ethanol 
on NMDAR function. 
 
Postsynaptic administration of TAT-STEP (C/S) blocks ethanol inhibition of NMDA 
EPSCs 
Intracellular injection of STEP (C/S) was previously found to increase NMDA currents21 
and to prevent STEP-mediated endocytosis of NMDARs25. To determine whether STEP 
mediates the inhibitory effect of ethanol on NMDA EPSCs, we administered  
TAT-STEP (C/S) intracellularly into postsynaptic neurons via the recording electrode. 
TAT-STEP (C/S) has a point mutation in its catalytic site that renders STEP catalytically 
inactive. TAT-STEP (C/S) binds to STEP substrates but does not dephosphorylate 
them, and consequently acts as a substrate-trapping protein27.  
TAT-STEP (C/S) was added to the recording microelectrode internal filling solution 
at a concentration of 30 nM. As described above and in other studies28, ethanol (80 
mM) inhibited NMDA EPSCs by 35 ± 4% in control neurons obtained from hippocampal 
slices. However, in neurons that were pre-administered with TAT-STEP (C/S), ethanol 
inhibition of NMDA EPSCs was prevented (Figure 2). Unexpectedly, an ethanol-
mediated enhancement of NMDA EPSCs (10.5 ± 4.9%) was observed in neurons pre-
administered with TAT-STEP (C/S) when compared to EPSCs recorded during baseline 
(pre-ethanol) and washout (post-ethanol) periods [t=2.143, p<0.05, Student’s t test].  A 
control TAT-Myc peptide (30 nM) did not affect the inhibitory actions of ethanol on 
NMDA EPSCs (36.2 ± 4.4% inhibition) and thus, the NMDA inhibition was similar to 
control EPSCs (Figure 2). Therefore, the effects of ethanol on NMDA EPSC amplitudes 
were significantly different between neurons pre-administered TAT-Myc and  
TAT-STEP (C/S) [t=6.894, p<0.001, Student’s t test]. These findings demonstrate that 
TAT-STEP (C/S) prevents ethanol inhibition of synaptic NMDA EPSCs.  
 
Ethanol fails to inhibit NMDA EPSCs in STEP KO mice  
We next investigated the effects of ethanol on NMDA EPSCs using STEP null mutant 
(KO) mice26. Figure 3 indicates that pharmacologically-isolated synaptic NMDA EPSCs 
were readily evoked by electrical stimulation at the stratum pyramidale in hippocampal 
slices prepared from wild type (WT) and STEP KO mice. There was no significant 
difference in the resting membrane potential of CA1 pyramidal neurons in brain slices 
from WT and STEP KO mice (-72.6 ± 1.3 and -70.1 ± 1.5 mV, respectively; t= 1.271, 
p=0.213, Student’s t test). In neurons from WT mice, bath application of ethanol (80 
mM) produced a decrease in synaptic NMDA EPSCs [-25.4 ± 1.9%; t= 13.368, p<0.001, 
compared to the baseline values, Student’s t test]. Ethanol inhibition of NMDA EPSPs in 
WT mice was reversed following washout of the ethanol. However, in neurons from 
STEP KO mice, bath application of ethanol (80 mM) produced a time-dependent 
enhancement of NMDA EPSCs [24.2 ± 4.6%; t=5.261, p<0.001, Student’s t test], 
compared to the baseline values. Enhancement of NMDA EPSCs by ethanol in STEP 
KO mice returned to baseline values upon washout of ethanol (Figure 3). This effect of 
ethanol was significantly different between WT and STEP KO mice [t=9.173, p<0.001, 
Student’s t test] during ethanol treatment (Figure 4). The results demonstrate that 
ethanol inhibits synaptic NMDA EPSCs in WT neurons, whereas ethanol actually 
enhances synaptic NMDA EPSCs in STEP KO neurons.  
To determine whether the changes in NMDA EPSCs were due to presynaptic 
alterations in glutamate release, we next measured paired-pulse facilitation (PPF) in 
hippocampal slices from WT and STEP KO mice in the presence and absence of 
ethanol. Paired-pulse stimulation with an inter-pulse interval of 50 ms (an interval that 
gave optimal facilitation) produced control PPFs with a paired-pulse ratio (PPR, 
peak2/peak1; P2/P1) of 1.75 ± 0.16 for WT and 1.82 ± 0.17 for STEP KO mice (Figure 
4). Ethanol did not significantly alter presynaptic glutamate release in STEP KO mice 
[F(1,22)=0.0391, p>0.845, two-way ANOVA] or in WT mice [F(1,22)=0.593, p>0.449, 
two-way ANOVA]. In addition, there was no significant interaction between genotype 
and ethanol treatment [F(1,22)=0.0396, p>0.844, two-way ANOVA]. Therefore, deletion 
of the STEP gene does not alter presynaptic glutamate release, and ethanol has no 
significant effect on presynaptic glutamatergic transmission. Therefore, these data 
indicate that ethanol inhibition of synaptic NMDA EPSCs is mediated by the STEP 
molecules that are localized in the postsynaptic neuron. 
 
Intracellular administration of wildtype TAT-STEP restores the inhibitory effects 
of ethanol on NMDA EPSCs in STEP KO neurons 
To conclusively demonstrate that STEP mediates the inhibitory effects of ethanol on 
NMDA EPSCs, we restore STEP activity by adding WT TAT-STEP back into neurons 
from STEP KO mice. WT TAT-STEP (30 nM) was pre-administered intracellularly to 
CA1 pyramidal neurons in slices prepared from WT and STEP KO mice. As described 
previously (Figure 3), ethanol (80 mM) inhibited NMDA EPSCs in neurons from WT 
mice by 35 ± 4% (Figure 5).  Pre-administration of WT TAT-STEP to WT neurons did 
not significantly alter the inhibitory effect of ethanol on NMDA EPSCs (Figure 5a). We 
again observed that ethanol (80 mM) significantly potentiated NMDA EPSCs in neurons 
from STEP KO mice (Figure 5c).  Importantly, pre-administration of WT TAT-STEP to 
neurons from STEP KO mice showed an  inhibitory effect of ethanol on NMDA EPSCs 
of 31.1 ± 4.4% [F(3,27)=51.134, p<0.001, one-way ANOVA] (Figure 5e).  These results 
indicate that the introduction of WT TAT-STEP into neurons from STEP KO mice 
restored the inhibitory effect of ethanol on NMDA EPSCs. 
 
Ethanol effects on GABAergic transmission do not differ between wild type and 
STEP KO mice. 
We have previously shown that ethanol potentiates synaptic GABAA receptor-mediated 
inhibitory postsynaptic currents (GABAA IPSCs) in rodent hippocampal slices28. 
Therefore, we next examined whether GABAA IPSCs in STEP KO mice were altered by 
ethanol.  Resting membrane potentials were not significantly different between neurons 
from WT (-72.5 ± 2.7 mV) and STEP KO (-69.5± 2.0 mV) mice for these experiments. 
Previous work has shown that electrical stimulation of the stratum pyramidale in several 
mouse and rat strains readily evokes synaptic GABAA IPSCs that are potentiated by 80 
mM ethanol29, 30.  Here we found that bath application of ethanol (80 mM) enhanced 
GABAA IPSCs in neurons from both WT and STEP KO mice (+29.8 ± 5.2% and +35.6 ± 
1.8%, respectively) [t=5.780, p=0.321, Student’s t test]. Paired-pulse determinations of 
GABAA IPSCs also are not different in the KO compared to the WT mice with respect to 
genotype [F(1,16)=3.691, p<0.075, two-way ANOVA] and to the effects of ethanol 
[F(1,16)=0.578, p>0.458, two-way ANOVA] (Figure 6). Therefore, we conclude that the 
potentiating effects of ethanol on GABAA IPSCs were not altered in the KO mice, so 
STEP does not seem to be involved in the ethanol action on GABAergic function.  
 
Ethanol fails to impair high frequency stimulus-induced LTP in STEP KO mice 
A number of previous studies have demonstrated that ethanol prevents induction of  
LTP31,32. NMDARs have been shown to be required for LTP induction in the CA1 region 
of the hippocampus33, and therefore, a widely accepted hypothesis underlying ethanol’s 
blockade of LTP induction involves ethanol’s inhibition of NMDAR function. Since 
ethanol fails to inhibit NMDAR function in STEP KO mice (Figure 3), we predicted that 
LTP would be observed in STEP KO mice even in the presence of ethanol. To test this 
assumption, high frequency stimulation (HFS) was applied to the Schaeffer-collateral 
commissural fiber pathway, and LTP was measured extracellularly in the CA1 region of 
hippocampal slices obtained from WT and STEP KO mice.  In slices from WT mice, 
HFS elicited robust LTP as measured by both the amplitude and slope of the fEPSP. 
Bath application of ethanol (80 mM) for 10 min prior to as well as during the HFS period 
blocked the induction of LTP in slices from WT mice (Figure 7).  In contrast, ethanol was 
unable to block the induction of LTP in slices from STEP KO mice [F(3,26)=5.443, 
p<0.005, one-way ANOVA]. Post-hoc pair-wise comparison shows that there was no 
significant difference in the slope of LTP in control slices from WT and STEP KO mice, 
and that ethanol only blocked the LTP in slices from WT mice (Figure 7e). Similar 
results were seen when the LTP amplitudes were measured (Figure 7f).  In conclusion, 
ethanol inhibition of LTP induction was not prevented in STEP KO mice.  
 
Discussion 
Previous work from our laboratory demonstrated that acute ethanol reduced 
NMDAR function and decreased tyrosine phosphorylation of NR2A and NR2B6. Given 
that the PTP inhibitor bpV(phen) prevented ethanol-induced inhibition of NMDAR 
function6, we concluded that the inhibitory effects of ethanol on NMDARs were 
mediated by PTPs. However, the identity of the PTP(s) mediating this inhibitory effect 
on NMDARs was unknown. In the present study, we examined whether STEP was the 
PTP responsible for ethanol’s inhibition of NMDAR activity. 
NMDAR activity is regulated by protein phosphorylation34, 35. Specifically, tyrosine 
phosphorylation of NMDARs by the Src family of protein kinases enhances receptor 
function36,37,38, whereas PTPs reduce NMDAR channel activity36, 21. In the CNS, several 
PTPs have been identified to influence NMDAR activity39, 40 ; however, these particular 
PTPs indirectly modulate NMDAR activity by dephosphorylating an inhibitory site on 
Src-family tyrosine kinases and consequently increase NMDAR function. We were in 
search of a PTP that directly dephosphorylates NMDAR subunits and would regulate 
the inhibitory effects of ethanol on NMDAR function.  One likely candidate is the PTP 
STEP. 
Two relevant studies by Pelkey et al.21 and by Braithwaite et al.24 demonstrated 
that the PTP STEP and NMDARs co-immunoprecipitate together, suggesting an 
interaction of STEP with NMDAR complexes. STEP reduces NMDAR function and 
negatively influences LTP21.  In addition, STEP is required for internalization of both 
AMPARs and NMDARs. Specifically, beta amyloid activation of STEP leads to 
dephosphorylation of the regulatory Tyr1472 on the NR2B subunit and promotes 
endocytosis of NMDARs25. Moreover, (RS)-3, 5-dihydroxyphenylglycine (DHPG) 
stimulation of hippocampal slices leads to STEP-mediated internalization of the AMPAR 
subunits GluR1/GluR241. Based on these results, we predicted that STEP is the PTP 
which regulates the inhibitory effects of ethanol on NMDAR activity. 
If ethanol inhibits NMDAR activity via STEP, we hypothesized that inhibition of 
STEP activity should attenuate ethanol-induced inhibition of NMDAR function. To test 
this possibility, we first investigated whether postsynaptic micro-injection of the 
substrate-trapping TAT-STEP (C/S) peptide27 prevented ethanol inhibition of NMDA 
EPSCs. Indeed, we found that TAT-STEP (C/S) attenuated the effects of ethanol on 
NMDA EPSCs, suggesting that competition for available endogenous STEP substrates 
sufficiently blocks the ability of ethanol to reduce NMDAR activity.  
Since TAT-STEP (C/S) binds to several STEP substrates12, 27, 26, 41 , we utilized 
STEP KO mice which were recently generated 26 . We tested the effects of ethanol on 
hippocampal synaptic NMDA EPSCs in WT and STEP KO mice. Synaptically evoked 
NMDA EPSCs were resistant to the inhibitory effects of ethanol in STEP KO mice, 
suggesting that STEP is necessary for ethanol’s inhibition of NMDA EPSCs. An 
important consideration is that compensatory mechanisms may occur in the STEP KO 
mice which contribute to the failure of ethanol to inhibit NMDA EPSCs in these mice. 
For example, previous studies in mice created with other gene deletions report that 
compensatory mechanisms develop and contribute to the behavioral effects of ethanol 
as a means of homeostasis42. To explore this possibility, we acutely restored WT TAT-
STEP to neurons from STEP KO slices and found that the ability of ethanol to inhibit 
NMDA EPSCs was rescued. This finding strongly supports the hypothesis that STEP is 
directly involved in mediating the ethanol inhibition of NMDA EPSCs. 
During ethanol application to STEP KO slices, we observed facilitation of NMDA 
EPSCs that continued during the early period of washout (Figure 3). This facilitation was 
not observed in neurons administered with TAT-STEP (C/S) or in WT mice. As 
discussed previously, one possible explanation could be that compensatory 
mechanisms arise during development of STEP KO mice. The hypothesis we favor is 
that the absence of STEP leads to increased tyrosine phosphorylation of STEP 
substrates under basal conditions. In support of this hypothesis, recent evidence 
demonstrates that STEP KO mice have elevated levels of pY1472-NR2B (Venkitaramani 
and Lombroso, unpublished observations) and pY204-ERK26.  A consequence of this 
elevated tyrosine phosphorylation is increased surface expression of NR1/NR2B 
(Venkitaramani and Lombroso, unpublished observations) and GluR1/2 in STEP KO 
mice41. Perhaps ethanol enhances NMDAR activity during ethanol application and early 
washout in STEP KO mice by aberrantly increasing the surface expression of NMDARs. 
We also investigated the effects of ethanol on LTP induction in STEP KO and 
WT mice. Pelkey et al21 previously showed that endogenous STEP functions as a 
“brake” to regulate NMDAR activity and LTP. We reasoned that removal of STEP might 
enhance the expression of LTP. To our surprise, we found that hippocampal LTP 
elicited by HFS does not differ between STEP KO and WT mice. One possible 
explanation for this result may be that STEP KO mice exhibit similar degrees of HFS-
induced LTP but that their threshold for induction is lower than WT mice.  Importantly, 
STEP KO mice are resistant to the inhibitory effects of ethanol on LTP induction in the 
CA1 region of the hippocampus, a brain region where LTP induction is NMDAR 
dependent31, 32. These results are consistent with the involvement of STEP in mediating 
the effects of ethanol on NMDAR activity in the hippocampus. 
Several reports have shown that PTPs, and in particular STEP, are critically 
involved in NMDAR and AMPAR internalization25, 41. For example, inhibition of PTPs 
enhances NMDAR surface expression43, 44, 45, and knock-down of STEP by RNA 
interference markedly increases the surface expression of functional NMDARs23.  
Phosphorylation of Y1472-NR2B is highest in synaptic membranes44, and 
dephosphorylation of Y1472-NR2B is required for endocytosis of NR2B-containing 
NMDARs7, 8.  Additionally, beta amyloid-induced NMDAR endocytosis requires activity 
of STEP for dephosphorylation of Tyr1472  -NR2B25. We predict that increased surface 
expression of NMDARs after RNAi of STEP23 is due to impaired STEP-dependent 
dephosphorylation of pY1472-NR2B, as well as increased activity of Fyn46, the Src-family 
member which phosphorylates pY1472-NR2B35.  Based on these studies, we propose 
that ethanol inhibition of NMDAR function is due to STEP-dependent endocytosis of 
NMDARs from neuronal surface membranes.  
In conclusion, we demonstrate that STEP plays a crucial role in regulating the 
inhibitory effects of ethanol on NMDARs in the hippocampus.  STEP KO mice are 
resistant to the disrupting effects of ethanol on NMDAR function and LTP induction, and 
the effects of ethanol on NMDARs are strongly implicated in ethanol tolerance and 
dependence5. As a result, STEP may be an important new target for the development of 
therapeutic strategies for treating alcoholism.  
 
 
 METHODS 
Reagents and animals. All procedures were approved by the Institutional Animal Care 
and Use Committee of the University of Colorado Denver and Health Sciences Center. 
STEP KO mice were generated by classical homologous recombination and back-
crossed for 7 generations onto C57/B6 mice26.  
We used a catalytically inactive mutant of STEP, in which an essential cysteine in the 
catalytic domain was converted to a serine (C/S).21,27  STEP is inactivated by this 
mutation, but still binds to its substrates and acts as a substrate-trapping protein47. We 
fused the human immunodeficiency virus-type 1, to the N-terminus of TAT-STEP (C/S) 
to make it cell-permeable48. A similar TAT-Myc fusion peptide was made and used as a 
control in these experiments.  
Hippocampal Slice Recordings. Acute hippocampal slices were prepared from 6-8 
weeks old male wild type mice, STEP null mutant mice, or Sprague-Dawley rats and 
placed in a storage chamber for at least 1.5 hr prior to recording30, 28. For whole-cell 
recording of NMDA EPSCs or GABAA IPSCs, a single slice was transferred to a 
recording chamber and superfused with artificial cerebrospinal fluid (aCSF) at a bulk 
flow rate of 2 ml/min. The aCSF consisted of (in mM): 126 NaCl, 3 KCl, 1.5 MgCl2,  
2.4 CaCl2, 1.2 NaHPO4, 11 D-glucose, 25.9 NaHCO3, saturated with 95% O2 and 5% 
CO2 at 32.5 ± 1.0 °C. A Flaming/Brown electrode puller (Sutter Instruments, Novato, 
CA) was used to fabricate whole-cell microelectrodes with resistances of 6-9 MΩ when 
filled with a K+-gluconate internal solution. The K+-gluconate internal solution contained 
(in mM): 130 K+-gluconate, 1 EGTA, 2 MgCl2, 0.5 CaCl2, 2.54 disodium ATP, and  
10 HEPES; adjusted to pH 7.3 with KOH and 280 mOsm. CA1 pyramidal neurons were 
recorded within the stratum pyramidale layer and electrically evoked synaptic responses 
were obtained by stimulation at the stratum pyramidale layer with twisted bipolar 
stimulating electrodes made from 0.0026-in diameter Formvar-coated nichrome  
wire49, 50  to activate presynaptic fibers on or near the pyramidal cell soma (proximal 
stimulation). Drugs were applied at 100-fold concentration by bath superfusion at 1/100 
of the aCSF bulk flow rate of 2 ml/min via calibrated syringe-pumps (Razel Scientific 
Instruments Inc, Stamford, CT) to obtain the desired concentrations in the bath 
perfusate. 
Measurement of GABAA IPSCs: CA1 pyramidal neurons were voltage-clamped to 
-55 mV (corrected for the liquid-junction potential) from the normal resting membrane 
potential of -65 to -70 mV. GABAA receptor-mediated IPSC (GABAA IPSCs) responses 
were evoked (200 μs, 4-10 V pulses) with a bipolar stimulating electrode at 60 s 
intervals placed in the stratum pyramidale approximately 200-300 μm from the recorded 
cell. 6-cyano-7-nitroquinoxaline-2,3-dione disodium salt (CNQX, 20 μM) and D (-)-2-
amino-5-phosphonovaleric acid (APV, 25 μM), were added to the superfused aCSF to 
block α-amino-3-hydroxy-5-methyl-4-isoxalone propionic acid (AMPA) and N-methyl-D-
aspartate (NMDA) receptor-mediated EPSCs, respectively. This stimulation-recording 
paradigm evokes synaptic GABAergic responses predominantly from proximal inputs 
(i.e., GABAA responses from interneurons that synapse on or near the soma of the 
recorded pyramidal cell in the stratum pyramidale). Since GABAB activity can reduce the 
effects of ethanol on the GABAA response, pretreatment with the GABAB antagonist, 3-
[[(3,4-dichlorophenyl) methyl]amino] propyl] diethoxymethyl) phosphinic acid  
(CGP-52432, 0.5 µM) was added to the bath perfusate. 
Measurement of NMDA EPSCs: CA1 pyramidal neurons were voltage-clamped at  
-60 mV (corrected for the liquid-junction potential) from the normal resting membrane 
potential of -65 to -70 mV. The NMDA receptor-mediated EPSCs (NMDA EPSCs) were 
isolated pharmacologically using CNQX (20 μM) and bicuculline methiodide (BMI, 
30 μM) to block AMPA and GABAA receptor-mediated currents, respectively. NMDA 
EPSC responses were evoked at proximal positions as described for recording GABAA 
responses (i.e., stimulation of glutamatergic neurons that synapse on or near the soma 
of the recorded pyramidal cell). Also, the GABAB receptor activity was inhibited by the 
GABAB antagonist, CGP-52432 (0.5 μM). 
 
Measurement of Long Term Potentiation. Synaptic responses were evoked with 
bipolar tungsten electrodes placed in the CA1 pyramidal cell layer. Test stimuli were 
delivered at 0.033 Hz with the stimulus intensity set to 40-50% of that which produced 
maximum synaptic responses. Tetanic stimulation consisted of two trains of 100 Hz 
stimuli lasting for 1 s each, with an inter-train interval of 15 s. Field potential recordings 
were made with glass micropipettes filled with aCSF and placed in the stratum radiatum 
approximately 200-300 μm from the cell body layer. In control wild type and STEP 
knockout mice, this stimulation caused a potentiated response (LTP) that persisted at 
an elevated level (> 20% above baseline) for more than 40 min. Field EPSP (fEPSP) 
slopes were calculated as the initial slope measured between 10-30% from the  origin of 
the negative deflection.  
 
Statistical Analysis.   All data were expressed as mean ± S.E.M. Significant 
differences between two groups were determined by unpaired t-test while significance 
among multiple groups were evaluated either by one-way or two-way ANOVA with 
Tukey’s post hoc pairwise comparisons. P values (α) less than 0.05 were set as 
significance throughout the experiments. Computer-assisted software Sigma Stat 
Program (SYSTAT SOFTWARE INC, San Jose CA) was used in statistical analysis. 
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Figure Legend 
 
Figure 1. The protein tyrosine phosphatase inhibitor bpV(phen) blocks ethanol 
inhibition of synaptic NMDA EPSCs. (a) Representative NMDA current traces of a 
neuron from a rat hippocampal slice shows that acute ethanol application inhibits 
synaptic NMDA EPSCs from control (Con) brain slices. (b) Representative NMDA 
EPSC traces of a CA1 neuron from a bpV(phen)-treated brain slice (bpV) shows that 
the effects of acute ethanol on NMDA EPSCs are blocked by 10 μM bpV(phen) 
treatment. (c) Representative traces show input-output (I/O) relationship of NMDA 
EPSCs. The stimulus strength (input) is shown as 1X, 2X, or 4X times of the threshold 
stimulus strength that can evoke an NMDA EPSC response. (d) The composite data 
show that bpV(phen) blocks the ethanol inhibition of NMDA EPSCs. Control cells 
(n=14); bpV(phen)-treated cells (n=8); *** p<0.001  
Scale bar represents 50 ms and 50 pA  
 
Figure 2. Microinjection of TAT-STEP (C/S) into postsynaptic neurons blocks the 
inhibitory effects of ethanol on NMDA EPSCs. (a) Current traces show that 
microinjection of Tat-Myc (Myc) does not alter the inhibitory effects of ethanol on NMDA 
EPSCs. (b) Administration of TAT-STEP (C/S) (STEP C/S) into the postsynaptic 
pyramidal neuron blocks the inhibitory effects of ethanol on NMDA EPSCs. (c) The 
composite data show that Tat-Myc (n=4) does not alter the effects of ethanol while TAT-
STEP (C/S) (n=5) blocks the effects of ethanol on the NMDA EPSCs.  *** p<0.001 
Scale bar represents 50 ms and 50 pA 
 
Figure 3. Ethanol fails to inhibit NMDA EPSCs in STEP KO mice. (a) Whole-cell 
current traces of a hippocampal CA1 neuron from a wild type (WT) mouse are shown. 
The NMDA EPSC trace that is measured at baseline (A), during ethanol application (B), 
an early period during ethanol washout (C), and a late period of ethanol washout (D) of 
a WT mouse (WT) at the times indicated in panel c. (b) Whole-cell current traces from a 
hippocampal CA1 neuron of the STEP KO mouse (KO) are shown. An NMDA EPSC 
that is measured at the time indicated in part c. (c) The time course of the effects of 
ethanol on NMDA EPSC amplitude from WT (   ●   , n=8 cells) or STEP KO (  ○ , n=10 
cells) mice. These data indicate that acute ethanol application inhibits NMDA EPSCs 
from WT mice, whereas acute ethanol has an enhancing effect on NMDA EPSCs from 
KO mice.  
 
Figure 4. Presynaptic glutamate release is not influenced by ethanol or genotype.   
(a) Representative NMDA EPSC traces from WT mice (n=10 cells) demonstrate that 
acute ethanol application inhibits the amplitude of NMDA EPSCs. (b) Representative 
NMDA EPSC traces from STEP KO neurons (n=10 cells) show that ethanol potentiates 
the amplitude of NMDA EPSCs. (c) The composite data show that acute ethanol 
application produces approximately a 28% reduction in the amplitude of synaptic NMDA 
EPSCs in WT mice, but it stimulates the NMDA EPSCs by 24% in STEP KO mice. 
Current traces show the paired pulse facilitation of synaptic NMDA EPSCs in WT (d) 
and STEP KO (e) mice. Although ethanol inhibits these responses in WT neurons and 
enhances these responses in STEP KO neurons, the paired pulse ratios remain 
unchanged in both genotypes. (f) The composite data show that the STEP gene 
deletion does not alter presynaptic events or ethanol effects on these events on 
NMDAR neurotransmission (n=5 for WT and n=7-8 for STEP KO neurons). *** p<0.001 
Scale bar represents 50 ms and 50 pA 
 
Figure 5. Microinjection of WT TAT-STEP restores the inhibitory effects of ethanol 
on NMDA EPSCs in neurons from STEP KO mice.  (a) Whole-cell recordings show 
that microinjection of vehicle (Con) does not alter the inhibitory effects of ethanol on 
NMDA EPSCs in neurons from WT mice (n=8 cells). (b) Representative NMDA EPSC 
traces show that intracellular injection of wild type TAT-STEP (STEP) into a neuron 
does not alter the effects of ethanol on NMDA EPSCs in WT mice (n=8 cells).  (c) 
Representative NMDA EPSC traces show that intracellular injection of vehicle (Con) 
does not alter the stimulatory effects of ethanol on NMDA EPSCs from STEP KO mice 
(n=10 cells), but it restores the effects of ethanol on NMDA EPSCs in STEP KO 
neurons (n=5 cells) (d). The composite data (e) show that there is sufficient STEP 
activity in WT neurons to mediate the action of ethanol on NMDARs, so that additional 
STEP does not further enhance the effects of ethanol. However, replacement of WT 
TAT-STEP can restore the effects of ethanol in STEP KO neurons. *** p<0.001     
Scale bar represents 50 ms and 50 pA 
 
Figure 6. GABAA IPSCs are potentiated in both WT and STEP KO mice. 
 Whole-cell current responses show synaptic GABAA IPSCs and the ethanol 
enhancement of these GABAA IPSCs from WT (a) and STEP KO (b) neurons. The 
composite data (c) show that ethanol stimulates GABAA IPSCs to a similar extent in 
both WT (n=5) and STEP KO (n=5) neurons. Paired-pulse responses and the effects of 
ethanol on these GABAA IPSCs in WT (d) and STEP KO (e) neurons are shown. The 
composite data (f) show that neither the control (Con) paired pulse ratio (PPR) nor the 
effects of ethanol (EtOH) on the PPR was altered in WT (n=5 cells) or in STEP KO (n=5 
cells). Scale bar represents 50 ms and 200 pA 
 
Figure 7. Ethanol fails to inhibit the induction of LTP in STEP KO mice. Field 
excitatory postsynaptic potential (fEPSP) traces show hippocampal LTP induction in 
brain slices treated with control aCSF (Con) or acute ethanol (80 mM) (EtOH) in WT (a) 
and STEP KO (b) mice.  High frequency stimulation (HFS, two trains of 100 Hz 
stimulation, separated by 15 s) of the stratum radiatum produces a robust LTP of the 
fEPSP slope in both WT (c) and STEP KO (d) mouse hippocampal slices under control 
conditions (  ●  ) or following 10 min of EtOH administration (  ○  ). However, after acute 
ethanol application, the same stimulation fails to induce LTP in WT mice, while LTP can 
still be obtained from STEP knockout mice. Mean changes in the slope (e) and 
amplitude (f) of the fEPSPs by ethanol from WT (n=8) and STEP KO (n=7) mice are 
shown. ** p<0.005 
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